110 related articles for article (PubMed ID: 8736322)
1. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids.
Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR
Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of topical clobetasol propionate by visual score, electrical impedance and laser Doppler flowmetry.
Emtestam L; Kuzmina N; Talme T
Skin Res Technol; 2007 Feb; 13(1):73-8. PubMed ID: 17250535
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous vasoconstrictor response to glucocorticoids in asthma.
Brown PH; Teelucksingh S; Matusiewicz SP; Greening AP; Crompton GK; Edwards CR
Lancet; 1991 Mar; 337(8741):576-80. PubMed ID: 1671942
[TBL] [Abstract][Full Text] [Related]
4. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging.
Sommer A; Veraart J; Neumann M; Kessels A
Acta Derm Venereol; 1998 Jan; 78(1):15-8. PubMed ID: 9498019
[TBL] [Abstract][Full Text] [Related]
6. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
7. The skin-blanching assay.
Smit P; Neumann HA; Thio HB
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1197-202. PubMed ID: 22303935
[TBL] [Abstract][Full Text] [Related]
8. Skin levels and vasoconstrictor assay of topically applied hydrocortisone.
Wallace SM; Falkenberg HM; Runikis JO; Stewart WD
Arch Dermatol; 1979 Apr; 115(4):440-1. PubMed ID: 434864
[TBL] [Abstract][Full Text] [Related]
9. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.
Feather JW; Ryatt KS; Dawson JB; Cotterill JA; Barker DJ; Ellis DJ
Br J Dermatol; 1982 Apr; 106(4):437-43. PubMed ID: 7073967
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tissue viability imaging and colorimetry: skin blanching.
Zhai H; Chan HP; Farahmand S; Nilsson GE; Maibach HI
Skin Res Technol; 2009 Feb; 15(1):20-3. PubMed ID: 19152574
[TBL] [Abstract][Full Text] [Related]
11. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study.
Andersen P; Milioni K; Maibach H
Br J Dermatol; 1993 Jun; 128(6):660-5. PubMed ID: 8338750
[TBL] [Abstract][Full Text] [Related]
12. Vasoconstrictive effect of topical applied corticosteroids measured by laser doppler imaging and reflectance spectroscopy.
Sommer A; Lucassen GW; Houben AJ; Neumann MH
Microvasc Res; 2003 May; 65(3):152-9. PubMed ID: 12711256
[TBL] [Abstract][Full Text] [Related]
13. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension.
Walker BR; Best R; Shackleton CH; Padfield PL; Edwards CR
Hypertension; 1996 Feb; 27(2):190-6. PubMed ID: 8567040
[TBL] [Abstract][Full Text] [Related]
14. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
[TBL] [Abstract][Full Text] [Related]
15. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
Schalla W; Schorning S
Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
[TBL] [Abstract][Full Text] [Related]
16. [Bioavailability evaluation of dermocorticoids using differential infrared thermography].
Luong MS; Luong MP; Lok C; Carmi E; Chaby G; Viseux V
Ann Dermatol Venereol; 2000; 127(8-9):701-5. PubMed ID: 11011158
[TBL] [Abstract][Full Text] [Related]
17. The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate.
Wu WM; Bodor ET; Howes J; Bodor N
Pharmazie; 2012 May; 67(5):406-10. PubMed ID: 22764572
[TBL] [Abstract][Full Text] [Related]
18. Topical corticosteroid-induced skin blanching measurement: eye or instrument?
Haigh JM; Smith EW
Arch Dermatol; 1991 Jul; 127(7):1065. PubMed ID: 1898473
[No Abstract] [Full Text] [Related]
19. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
